| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Lakeshore Hospital And Research Centre Ltd |
| PARTICULARS | 31 March 2023 | 31 March 2022 |
| ASSETS | ||
| Non-current assets | ||
| Property, Plant and Equipment | 32,764.38 | 34,051.02 |
| Capital work-in-progress | 567.26 | 15.29 |
| Other Intangible assets | 44.09 | 52.97 |
| Right-of-use assets | 423.4 | 479.82 |
| Financial Assets | ||
| Other financial assets | 1,321.66 | 1,938.63 |
| Non-current tax assets (net) | 458.65 | 592.53 |
| Other non-current assets | 155.15 | 216.47 |
| 35,734.59 | 37,346.73 | |
| Current assets | ||
| Inventories | 1,271.85 | 1,106.15 |
| Financial Assets | ||
| Trade receivables | 1,998.89 | 2,013.45 |
| Cash and cash equivalents | 3,663.15 | 1,162.36 |
| Bank balances other than (ii) above | 6,178.19 | 3,898.73 |
| Loans | 5.58 | 6.64 |
| Other financial assets | 986.13 | 669.99 |
| Other current assets | 187.33 | 190.26 |
| 14,291.12 | 9,047.58 | |
| Total Assets | 50,025.71 | 46,394.31 |
| EQUITY AND LIABILITIES | ||
| Equity : | ||
| Equity Share capital | 10,000.00 | 10,000.00 |
| Other Equity | 27,344.92 | 23,121.22 |
| 37,344.92 | 33,121.22 | |
| Liabilities : | ||
| Non-current liabilities | ||
| Financial Liabilities | ||
| Borrowings | 723.56 | 1,300.95 |
| Lease liabilities | 427.46 | 472.04 |
| Other financial liabilities | - | 841.83 |
| Provisions | 1,102.09 | 1,070.88 |
| Deferred tax liabilities (Net) | 1,980.75 | 1,619.83 |
| Other non-current liabilities | 327.02 | 333.26 |
| 4,560.88 | 5,638.79 | |
| Current liabilities | ||
| Financial Liabilities | ||
| Borrowings | 578.85 | 578.85 |
| Lease liabilities | 54.47 | 51.5 |
| Trade payables | ||
| Total outstanding dues of micro enterprises and small enterprises | 106.11 | 138.52 |
| Total outstanding dues of creditors other than micro enterprises and small enterprises | 3,433.27 | 3,181.46 |
| Other financial liabilities | 3,521.04 | 3,295.28 |
| Other current liabilities | 318.21 | 295.52 |
| Provisions | 107.96 | 93.17 |
| 8,119.91 | 7,634.30 | |
| Total Equity and Liabilities | 50,025.71 | 46,394.31 |
Lakeshore Hospital And Research Centre Limited Profit & Loss Statement (Rs. In Lakhs)
| PARTICULARS | 31 March 2023 | 31 March 2022 |
| Income: | ||
| Revenue from operations | 41,918.42 | 35,858.70 |
| Other income | 535.62 | 307.11 |
| Total Income | 42,454.04 | 36,165.81 |
| Expenses: | ||
| Purchase of Medicines & Consumables | 11,170.49 | 10,251.14 |
| Changes in inventories of Medicines & Consumables | -165.7 | -186.46 |
| Employee benefits expense | 6,383.50 | 6,282.48 |
| Finance costs | 211.01 | 257.3 |
| Depreciation and amortisation expense | 2,269.19 | 2,146.15 |
| Other expenses | 14,344.09 | 11,337.27 |
| Total expenses | 34,212.58 | 30,087.88 |
| Profit before tax | 8,241.46 | 6,077.93 |
| Tax expense: | ||
| Current tax | 2,660.93 | 1,520.99 |
| Tax for earlier years | 17.09 | 7.93 |
| Deferred tax | -188.44 | 260.94 |
| 2,489.58 | 1,789.86 | |
| Profit for the year | 5751.88 | 4288.07 |
| Other comprehensive income | ||
| Items that will not be reclassified to profit or loss | ||
| Remeasurements of post employment benefit obligations | -39.76 | -187.59 |
| Income tax relating to items that will not be reclassified to profit or loss | 11.58 | 54.63 |
| Total other comprehensive income for the year | -28.18 | -132.96 |
| Total Comprehensive Income for the year | 5,723.70 | 4,155.11 |
| Earnings per equity share of Rs 10 each: | ||
| Basic (`) | 5.75 | 4.29 |
| Diluted (`) | 5.75 | 4.29 |
Lakeshore Hospital And Research Centre Limited Consolidated Cash Flow Statement (Rs. In Lakhs)
| Particulars | 31 March 2023 | 31 March 2022 |
| Cash flow from operating activites | ||
| Profit before tax | 8,201.70 | 5,890.34 |
| Adjustments for : | ||
| Depreciation and amortisation | 2,269.19 | 2,146.15 |
| Interest expense | 211.01 | 257.3 |
| Interest income | -416.18 | -168.7 |
| Net (Profit)/ Loss on sale/write off of Property Plant and Equipment | 67.08 | 237.38 |
| Government grant income | -37.44 | -23.34 |
| Bad debts and advances written off | - | - |
| Provision for doubtful debts | 1,098.86 | 400 |
| Operating cash flow before working capital changes | 11,394.22 | 8,739.13 |
| Movements in working capital : | ||
| (Increase) / decrease in inventories | -165.7 | -186.46 |
| (Increase) / decrease in trade and other receivables | -2,872.51 | -5,629.77 |
| Increase / (decrease) in trade and other payables | -876.04 | 1,211.64 |
| 7,479.97 | 4,134.54 | |
| Direct taxes paid net of refunds | -1,983.24 | -1,015.20 |
| Net cash flows from operating activities (A) | 5,496.73 | 3,119.34 |
| Cashflow from investing activities | ||
| Additions to Property, Plant & Equipment (including capital work in progress) | -903.62 | -2,645.57 |
| Investment in subsidiaries | - | - |
| Sale or withdrawal of property, plant and equipment | 9.19 | 124.33 |
| Interest received | 229.75 | 117.51 |
| Net cash flows from investing activites (B) | -664.68 | -2,403.73 |
| Cashflow from financing activities | ||
| Proceeds/(Repayment) of Buyers credit/ Term Loan | -577.39 | -1,841.69 |
| Movement in Short term borrowings (Net) | - | - |
| Dividend paid | -1,500.67 | -497.72 |
| Dividend distribution tax paid | - | - |
| Payment of lease liabilities | -83.86 | -73.81 |
| Interest paid | -169.34 | -225.84 |
| Net cash flows from financing activities (C) | -2,331.26 | -2,639.06 |
| Net Increase in Cash & Cash Equivalents (A)+(B)+(C) | 2,500.79 | -1,923.45 |
| Cash and cash equivalent at the beginning of the Year | 1,162.36 | 3,085.81 |
| Cash and cash equivalent at the end of the Year | ||
| Cash on hand | 23.22 | 30.79 |
| Balance with Banks in current account and deposit account | 3,639.93 | 1,131.57 |
| Cash and cash equivalents | 3,663.15 | 1,162.36 |
| Net increase/(decrease) in Cash and Cash equivalents | 2,500.79 | -1,923.45 |
1. Cash Flow from Operating Activities:
- This section begins with the profit before tax, which indicates the company 's earnings before tax deductions.
- Adjustments are made for non-cash expenses like depreciation and amortization, as well as for interest expenses and income.
- The net profit or loss from the sale or write-off of Property, Plant, and Equipment is accounted for here, along with any government grant income.
- After these adjustments, the operating cash flow before working capital changes is calculated.
- Movements in working capital, such as changes in inventories, receivables, and payables, are then factored in.
- Direct taxes paid, net of refunds, are deducted to arrive at the net cash flows from operating activities.
2. Cash Flow from Investing Activities:
- This section covers cash flows related to investments in assets and securities.
- Additions to Property, Plant & Equipment (PPE) are recorded as cash outflows.
- Any investments made in subsidiaries are also noted.
- Cash received from the sale or withdrawal of PPE and interest income earned are included.
- The net cash flows from investing activities are calculated by subtracting cash outflows from cash inflows.
3. Cash Flow from Financing Activities:
- Financing activities involve cash flows related to raising and repaying capital.
- Proceeds from or repayments of buyers ' credit or term loans are recorded, along with any changes in short-term borrowings.
- Dividends paid to shareholders and any dividend distribution tax are accounted for as cash outflows.
- Payments of lease liabilities and interest paid are also included.
- The net cash flows from financing activities are calculated by summing up cash inflows and outflows.
4. Net Increase in Cash & Cash Equivalents:
- This section calculates the overall change in cash and cash equivalents during the period.
- It adds the net cash flows from operating, investing, and financing activities to determine the total increase or decrease in cash.
- The cash and cash equivalents at the beginning of the year are added to this total to find the ending balance of cash and cash equivalents.
5. Cash and Cash Equivalents at the Beginning and End of the Year:
- The cash and cash equivalents at the beginning of the year provide the starting point for the analysis.
- The ending balance of cash and cash equivalents is calculated by adding the net increase or decrease in cash to the beginning balance.
| Particulars | 2023 | 2022 |
| (a) Current Ratio | 1.76 | 1.19 |
| (b) Debt-Equity Ratio | 0.03 | 0.06 |
| (c) Debt Service Coverage Ratio | 9.83 | 7.81 |
| (d) Return on Equity Ratio | 0.16 | 0.14 |
| (e) Inventory Turnover Ratio | 9.26 | 9.94 |
| (f) Trade Receivables Turnover Ratio | 20.89 | 18.74 |
| (g) Trade Payables Turnover Ratio | 3.26 | 3.10 |
| (h) Net Capital Turnover Ratio | 6.79 | 25.37 |
| (i) Net Profit Ratio | 0.14 | 0.12 |
Insights into the financial health and performance of the company in 2023 and 2022:
(a) Current Ratio:
- The current ratio measures a company 's ability to pay its short-term obligations with its short-term assets.
- In 2023, the current ratio is 1.76, indicating that the company has 1.76 times more current assets than current liabilities.
- In 2022, the current ratio was lower at 1.19, suggesting a potential improvement in the company 's liquidity position over the year.
(b) Debt-Equity Ratio:
- The debt-equity ratio compares a company 's total debt to its shareholders ' equity.
- In 2023, the ratio is 0.03, indicating that the company 's debt is very low compared to its equity.
- Similarly, in 2022, the ratio was slightly higher at 0.06, suggesting a slight increase in debt relative to equity compared to 2023.
(c) Debt Service Coverage Ratio:
- The debt service coverage ratio measures a company 's ability to cover its debt obligations with its operating income.
- In 2023, the ratio is 9.83, indicating a strong ability to cover debt payments with operating income.
- In 2022, the ratio was slightly lower at 7.81, suggesting a relatively weaker coverage of debt payments compared to 2023.
(d) Return on Equity Ratio:
- The return on equity (ROE) ratio measures the profitability of a company in relation to its shareholders ' equity.
- In 2023, the ROE ratio is 0.16, indicating that the company generated a return of 16% on its shareholders ' equity.
- In 2022, the ratio was slightly lower at 0.14, suggesting a slight decrease in profitability compared to 2023.
(e) Inventory Turnover Ratio:
- The inventory turnover ratio measures how efficiently a company manages its inventory.
- In 2023, the ratio is 9.26, indicating that the company turns over its inventory approximately 9.26 times during the year.
- In 2022, the ratio was slightly higher at 9.94, suggesting a slight decrease in inventory turnover efficiency compared to 2023.
(f) Trade Receivables Turnover Ratio:
- The trade receivables turnover ratio measures how efficiently a company collects its accounts receivable.
- In 2023, the ratio is 20.89, indicating that the company collects its receivables approximately 20.89 times during the year.
- In 2022, the ratio was slightly lower at 18.74, suggesting a slight improvement in receivables turnover efficiency compared to 2023.
(g) Trade Payables Turnover Ratio:
- The trade payables turnover ratio measures how efficiently a company manages its accounts payable.
- In 2023, the ratio is 3.26, indicating that the company pays its suppliers approximately 3.26 times during the year.
- In 2022, the ratio was slightly lower at 3.10, suggesting a slight decrease in payables turnover efficiency compared to 2023.
(h) Net Capital Turnover Ratio:
- The net capital turnover ratio measures how efficiently a company utilizes its capital to generate revenue.
- In 2023, the ratio is 6.79, indicating that the company generates revenue of 6.79 times its net capital.
- In 2022, the ratio was significantly higher at 25.37, suggesting a notable decrease in capital turnover efficiency compared to 2023.
(i) Net Profit Ratio:
- The net profit ratio measures the profitability of a company in relation to its revenue.
- In 2023, the net profit ratio is 0.14, indicating that the company generates a net profit of 14% of its revenue.
- In 2022, the ratio was slightly lower at 0.12, suggesting a slight decrease in profitability compared to 2023.
|
Particulars |
2023 |
|
Dividend (final + interim) (In Rs.) |
1.70 |
